Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Perez Insider Profile
4 Followers
Robert Perez, CEO, Director at Cubist Pharma, holds 15.81K shares in Vir Biotechnology (Ticker: VIR), holds 0.00 shares in Spark Therapeutics (Ticker: ONCE), holds 33.63K shares in Amag Pharmaceuticals (Ticker: AMAG).
Robert Perez Cubist Pharma (CBST)CEO, Director
Cubist Pharma (CBST)
CEO, Director
Not Ranked
Robert Perez has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Perez holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robert Perez
Robert Perez's Trading History
Cubist Pharma
Jan 21, 2015
―
Uninformative Sell
5.34M
―
Spark Therapeutics
Dec 17, 2019
―
Uninformative Sell
286.25K
$0.00
Cogent Biosciences
―
Director
―
―
Vir Biotechnology
May 24, 2023
Director
Uninformative Buy
―
$151.11K
Third Harmonic Bio, Inc.
―
Director
―
―
Amag Pharmaceuticals
May 20, 2019
―
Uninformative Buy
―
$462.40K
Cidara Therapeutics
Apr 21, 2015
Director
Informative Buy
80.00K
$63.00K
Larimar Therapeutics
Jan 28, 2019
Director
Uninformative Buy
19.37K
$85.56K
Salarius Pharmaceuticals
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Robert Perez's performance on stock
You May Also Like
Robert Perez insider profile FAQ
What is the percentage of profitable transactions made by Robert Perez?
The percentage of profitable transactions made by Robert Perez is ―.
What is the average return per transaction made by Robert Perez?
The average return per transaction made by Robert Perez is ―.
What stocks does Robert Perez hold?
Robert Perez holds: CBST, ONCE, COGT, VIR, THRD, AMAG, CDTX, LRMR, SLRX stocks.
What was Robert Perez’s latest transaction?
Robert Perez latest transaction was an Uninformative Buy of ―.
What was Robert Perez's most profitable transaction?
Robert Perez’s most profitable transaction was an Informative Buy of CDTX stock on April 21, 2015. The return on the trade was -4.90%.
What is Robert Perez's role in Cubist Pharma?
Robert Perez's role in Cubist Pharma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.